Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition

Human enteroviruses are responsible for diverse diseases, from mild respiratory symptoms to fatal neurological complications. Currently, no registered antivirals have been approved for clinical therapy. Thus, a therapeutic agent for the enterovirus-related disease is urgently needed. Remdesivir (GS-...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Microbiol
Päätekijät: Ye, Wei, Yao, Min, Dong, Yangchao, Ye, Chuantao, Wang, Dan, Liu, He, Ma, Hongwei, Zhang, Hui, Qi, Libin, Yang, Yuewu, Wang, Yuan, Zhang, Liang, Cheng, Linfeng, Lv, Xin, Xu, Zhikai, Lei, Yingfeng, Zhang, Fanglin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Microbiology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7304253/
https://ncbi.nlm.nih.gov/pubmed/32595613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2020.01105
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia